

Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|7|13|1291-1296
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.7, Iss.13, 2001-09, pp. : 1291-1296
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Tubulin-Targeting Agents in Hybrid Drugs
Current Medicinal Chemistry, Vol. 17, Iss. 7, 2010-03 ,pp. :


PPAR-γ inhibitors as novel tubulin-targeting agents
Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. :



